Indocyanine green angiography: a perspective on use in the clinical setting.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21501704.
- Also identified by DOI 10.1016/j.ajo.2011.01.043.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To review the history of indocyanine green (ICG) angiography and to present a personal perspective on its use in the clinical setting today. Perspective with literature review and opinions based on personal experience. To acquire views from international retinal physicians experienced with the technique on uses in their facilities and to compare them to the author's personal standards. The author and contributing retinal physicians had surprisingly similar views for most, but not all, applications for ICG angiography use in the clinical setting. ICG angiography is recommended for a few highly selective chorioretinal disorders, including certain forms of neovascularization in age-related macular degeneration, other neovascular maculopathies, chronic central serous chorioretinopathy, choroidal hemangiomas, and posterior uveitis.
Medical subject headings
- Coloring Agents
- Fluorescein Angiography
- Indocyanine Green